Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands.
dc.contributor.author | Igloi, Zsὁfia | |
dc.contributor.author | Velzing, Jans | |
dc.contributor.author | van Beek, Janko | |
dc.contributor.author | van de Vijver, David | |
dc.contributor.author | Aron, Georgina | |
dc.contributor.author | Ensing, Roel | |
dc.contributor.author | Benschop, Kimberley | |
dc.contributor.author | Han, Wanda | |
dc.contributor.author | Boelsums, Timo | |
dc.contributor.author | Koopmans, Marion | |
dc.contributor.author | Geurtsvankessel, Corine | |
dc.contributor.author | Molenkamp, Richard | |
dc.date.accessioned | 2021-05-23T17:51:43Z | |
dc.date.available | 2021-05-23T17:51:43Z | |
dc.date.issued | 2021-03-16 | |
dc.identifier.pmid | 33724916 | |
dc.identifier.doi | 10.3201/eid2705.204688 | |
dc.identifier.uri | http://hdl.handle.net/10029/624978 | |
dc.language.iso | en | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Roche | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | clinical evaluation | en_US |
dc.subject | coronavirus disease | en_US |
dc.subject | diagnostics | en_US |
dc.subject | rapid antigen test | en_US |
dc.subject | respiratory infections | en_US |
dc.subject | severe acute respiratory syndrome coronavirus 2 | en_US |
dc.subject | the Netherlands | en_US |
dc.subject | viruses | en_US |
dc.subject | zoonoses | en_US |
dc.title | Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands. | en_US |
dc.type | Article | en_US |
dc.identifier.eissn | 1080-6059 | |
dc.identifier.journal | Emerg Infect Dis 2021; 27(5):1323-9 | en_US |
dc.source.journaltitle | Emerging infectious diseases | |
dc.source.volume | 27 | |
dc.source.issue | 5 | |
dc.source.beginpage | 1323 | |
dc.source.endpage | 1329 | |
dc.source.country | United States |